{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:00:36Z","timestamp":1792821636276,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1136\/annrheumdis-2011-200424","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T00:20:05Z","timestamp":1326846005000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation"],"prefix":"10.1016","volume":"71","author":[{"given":"Jan Piet","family":"van Hamburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Asmawidjaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Davelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M C","family":"Mus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferry","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes P T M","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M W","family":"Hazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J E M","family":"Dolhain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A G M","family":"Bakx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lubberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-200424_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrrheum.2009.80","article-title":"Type 17 T helper cells-origins, features and possible roles in rheumatic disease","volume":"5","author":"Annunziato","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200424_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nri2804","article-title":"The changing face of rheumatoid arthritis: sustained remission for all","volume":"10","author":"Isaacs","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2007.09.014","article-title":"IL-17\/Th17 targeting: on the road to prevent chronic destructive arthritis","volume":"41","author":"Lubberts","year":"2008","journal-title":"Cytokine"},{"key":"10.1136\/annrheumdis-2011-200424_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","article-title":"IL-17 as a future therapeutic target for rheumatoid arthritis","volume":"5","author":"van den Berg","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200424_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2011-200424_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-009-0189-9","article-title":"Th17 cytokines and arthritis","volume":"32","author":"Lubberts","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1136\/annrheumdis-2011-200424_bib10","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2011-200424_bib11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/art.24329","article-title":"GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis","volume":"60","author":"van Hamburg","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1136\/annrheumdis-2011-200424_bib15","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-200424_bib16","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.30093","article-title":"Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production","volume":"63","author":"van Hamburg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib19","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.0801543","article-title":"Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response","volume":"182","author":"Tang","year":"2009","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib20","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.4049\/jimmunol.177.12.8504","article-title":"Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol","volume":"177","author":"Penna","year":"2006","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.174.1.270","article-title":"Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis","volume":"174","author":"Gauzzi","year":"2005","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jsbmb.2004.03.014","article-title":"Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system","volume":"89-90","author":"Mathieu","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1136\/annrheumdis-2011-200424_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene","volume":"101","author":"D'Ambrosio","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/annrheumdis-2011-200424_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib25","doi-asserted-by":"crossref","first-page":"38751","DOI":"10.1074\/jbc.C110.185777","article-title":"Vitamin D suppresses Th17 cytokine production by inducing C\/EBP homologous protein (CHOP) expression","volume":"285","author":"Chang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1136\/annrheumdis-2011-200424_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni.1851","article-title":"Vitamin D controls T cell antigen receptor signaling and activation of human T cells","volume":"11","author":"von Essen","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.25043","article-title":"1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis","volume":"62","author":"Colin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib28","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/en.2008-0078","article-title":"Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells","volume":"149","author":"Borgogni","year":"2008","journal-title":"Endocrinology"},{"key":"10.1136\/annrheumdis-2011-200424_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000058001","article-title":"Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3","volume":"128","author":"Rausch-Fan","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"Pt 5","key":"10.1136\/annrheumdis-2011-200424_bib30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"10.1136\/annrheumdis-2011-200424_bib31","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib32","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","article-title":"IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis","volume":"177","author":"Spach","year":"2006","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2011-200424_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jn\/128.1.68","article-title":"1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis","volume":"128","author":"Cantorna","year":"1998","journal-title":"J Nutr"},{"key":"10.1136\/annrheumdis-2011-200424_bib34","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1186\/ar3195","article-title":"Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability","volume":"12","author":"Rossini","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-200424_bib35","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s11033-010-0477-4","article-title":"Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis","volume":"38","author":"Lee","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1136\/annrheumdis-2011-200424_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/rheumatology\/ken394","article-title":"Vitamin D and autoimmune rheumatic diseases","volume":"48","author":"Cutolo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-200424_bib37","first-page":"453","article-title":"Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients","volume":"17","author":"Andjelkovic","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200424_bib38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.10816","article-title":"Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy","volume":"48","author":"Miossec","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/ar12","article-title":"The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion","volume":"1","author":"Tetlow","year":"1999","journal-title":"Arthritis Res"},{"key":"10.1136\/annrheumdis-2011-200424_bib40","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200424_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2011-200424_bib42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","article-title":"Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety","volume":"69","author":"Vieth","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1136\/annrheumdis-2011-200424_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-12-386960-9.00014-9","article-title":"Vitamin D endocrine system and the immune response in rheumatic diseases","volume":"86","author":"Cutolo","year":"2011","journal-title":"Vitam Horm"},{"key":"10.1136\/annrheumdis-2011-200424_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015469","article-title":"In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection","volume":"5","author":"Nelson","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672418939X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672418939X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-200424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:06:34Z","timestamp":1737248794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672418939X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S000349672418939X"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200424","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}